Clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study

Korkmaz, Serdal; Dal, Mehmet; Berber, Ilhami; Sahin, Deniz; Dogu, Mehmet; Ayyildiz, Orhan; Nizam, Ilknur; Albayrak, Murat; Esen, Ramazan; Namdaroglu, Sinem; ŞENCAN, MEHMET; AKAY, OLGA; Hacioglu, Sibel; Yildirim, Rahsan; Eser, Ali; TOMBAK, ANIL; Pala, Cigdem; İLHAN, OSMAN

doi:10.1111/ggi.12341

Clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study

Copy For Citation

Korkmaz S., Dal M. S., Berber I., Sahin D. G., Dogu M. H., Ayyildiz O., ...More

GERIATRICS & GERONTOLOGY INTERNATIONAL, vol.15, no.6, pp.729-735, 2015 (SCI-Expanded)

Publication Type: Article / Article
Volume: 15 Issue: 6
Publication Date: 2015
Doi Number: 10.1111/ggi.12341
Journal Name: GERIATRICS & GERONTOLOGY INTERNATIONAL
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
Page Numbers: pp.729-735
Keywords: chronic myeloid leukemia, dasatinib, elderly patients, imatinib, nilotinib, CHRONIC-PHASE, MYELOPROLIFERATIVE DISORDERS, 1ST-LINE TREATMENT, IMATINIB TREATMENT, CML, INTERFERON, RECOMMENDATIONS, CYTARABINE, MANAGEMENT, NILOTINIB
Van Yüzüncü Yıl University Affiliated: Yes

Abstract

AimsWe aimed to investigate whether older age leads to limitations in the starting dose of imatinib in daily treatment of chronic myeloid leukemia, and to determine the compliance of elderly patients with tyrosine kinase inhibitors (TKI) therapy.